Found 100 results
Author [ Keyword(Desc)] Title Type Year
Filters: Author is Jariwalla, R J  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Cell Survival
Harakeh S, Niedzwiecki A, Jariwalla RJ.  1994.  Mechanistic aspects of ascorbate inhibition of human immunodeficiency virus.. Chem Biol Interact. 91(2-3):207-15.
Cell Transformation, Viral
Ali MA, McWeeney D, Milosavljević A, Jurka J, Jariwalla RJ.  1991.  Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2.. Proc Natl Acad Sci U S A. 88(18):8257-61.
Cells, Cultured
Ali MA, McWeeney D, Milosavljević A, Jurka J, Jariwalla RJ.  1991.  Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2.. Proc Natl Acad Sci U S A. 88(18):8257-61.
Harakeh S, Jariwalla RJ.  1991.  Comparative study of the anti-HIV activities of ascorbate and thiol-containing reducing agents in chronically HIV-infected cells.. Am J Clin Nutr. 54(6 Suppl):1231S-1235S.
Chemotaxis, Leukocyte
Jariwalla RJ, Harakeh S.  1996.  Antiviral and immunomodulatory activities of ascorbic acid.. Subcell Biochem. 25:213-31.
Chlorocebus aethiops
Ali MA, McWeeney D, Milosavljević A, Jurka J, Jariwalla RJ.  1991.  Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2.. Proc Natl Acad Sci U S A. 88(18):8257-61.
Cloning, Molecular
Ali MA, Prakash SS, Jariwalla RJ.  1992.  Localization of the antigenic sites and intrinsic protein kinase domain within a 300 amino acid segment of the ribonucleotide reductase large subunit from herpes simplex virus type 2.. Virology. 187(1):360-7.
Ali MA, McWeeney D, Milosavljević A, Jurka J, Jariwalla RJ.  1991.  Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2.. Proc Natl Acad Sci U S A. 88(18):8257-61.
DNA Mutational Analysis
Ali MA, McWeeney D, Milosavljević A, Jurka J, Jariwalla RJ.  1991.  Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2.. Proc Natl Acad Sci U S A. 88(18):8257-61.
DNA, Viral
Ali MA, McWeeney D, Milosavljević A, Jurka J, Jariwalla RJ.  1991.  Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2.. Proc Natl Acad Sci U S A. 88(18):8257-61.
Epitopes
Ali MA, Prakash SS, Jariwalla RJ.  1992.  Localization of the antigenic sites and intrinsic protein kinase domain within a 300 amino acid segment of the ribonucleotide reductase large subunit from herpes simplex virus type 2.. Virology. 187(1):360-7.
Genes, Reporter
Harakeh S, Niedzwiecki A, Jariwalla RJ.  1994.  Mechanistic aspects of ascorbate inhibition of human immunodeficiency virus.. Chem Biol Interact. 91(2-3):207-15.
Harakeh S, Niedzwiecki A, Jariwalla RJ.  1994.  Mechanistic aspects of ascorbate inhibition of human immunodeficiency virus.. Chem Biol Interact. 91(2-3):207-15.
Genes, Viral
Ali MA, McWeeney D, Milosavljević A, Jurka J, Jariwalla RJ.  1991.  Enhanced malignant transformation induced by expression of a distinct protein domain of ribonucleotide reductase large subunit from herpes simplex virus type 2.. Proc Natl Acad Sci U S A. 88(18):8257-61.
Glutathione
Harakeh S, Jariwalla RJ.  1991.  Comparative study of the anti-HIV activities of ascorbate and thiol-containing reducing agents in chronically HIV-infected cells.. Am J Clin Nutr. 54(6 Suppl):1231S-1235S.
HIV
Harakeh S, Jariwalla RJ.  1997.  NF-kappa B-independent suppression of HIV expression by ascorbic acid.. AIDS Res Hum Retroviruses. 13(3):235-9.
Harakeh S, Niedzwiecki A, Jariwalla RJ.  1994.  Mechanistic aspects of ascorbate inhibition of human immunodeficiency virus.. Chem Biol Interact. 91(2-3):207-15.
Harakeh S, Niedzwiecki A, Jariwalla RJ.  1994.  Mechanistic aspects of ascorbate inhibition of human immunodeficiency virus.. Chem Biol Interact. 91(2-3):207-15.
Harakeh S, Jariwalla RJ.  1995.  Ascorbate effect on cytokine stimulation of HIV production.. Nutrition. 11(5 Suppl):684-7.
Harakeh S, Jariwalla RJ.  1991.  Comparative study of the anti-HIV activities of ascorbate and thiol-containing reducing agents in chronically HIV-infected cells.. Am J Clin Nutr. 54(6 Suppl):1231S-1235S.
HIV Long Terminal Repeat
Harakeh S, Niedzwiecki A, Jariwalla RJ.  1994.  Mechanistic aspects of ascorbate inhibition of human immunodeficiency virus.. Chem Biol Interact. 91(2-3):207-15.
Harakeh S, Niedzwiecki A, Jariwalla RJ.  1994.  Mechanistic aspects of ascorbate inhibition of human immunodeficiency virus.. Chem Biol Interact. 91(2-3):207-15.
Humans
Jariwalla RJ, Harakeh S.  1996.  Antiviral and immunomodulatory activities of ascorbic acid.. Subcell Biochem. 25:213-31.
Harakeh S, Jariwalla RJ.  1997.  NF-kappa B-independent suppression of HIV expression by ascorbic acid.. AIDS Res Hum Retroviruses. 13(3):235-9.
Harakeh S, Jariwalla RJ.  1991.  Comparative study of the anti-HIV activities of ascorbate and thiol-containing reducing agents in chronically HIV-infected cells.. Am J Clin Nutr. 54(6 Suppl):1231S-1235S.

Pages